Cargando…
Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids
In vitro cell cultures are frequently used to define the molecular background of drug resistance. The majority of currently available data have been obtained from 2D in vitro cultures, however, 3D cell culture systems (spheroids) are more likely to behave similarly to in vivo conditions. Our major a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471197/ https://www.ncbi.nlm.nih.gov/pubmed/32613561 http://dx.doi.org/10.1007/s12253-020-00837-9 |
_version_ | 1783578733843578880 |
---|---|
author | Koroknai, Viktoria Patel, Vikas Szász, István Ádány, Róza Balazs, Margit |
author_facet | Koroknai, Viktoria Patel, Vikas Szász, István Ádány, Róza Balazs, Margit |
author_sort | Koroknai, Viktoria |
collection | PubMed |
description | In vitro cell cultures are frequently used to define the molecular background of drug resistance. The majority of currently available data have been obtained from 2D in vitro cultures, however, 3D cell culture systems (spheroids) are more likely to behave similarly to in vivo conditions. Our major aim was to compare the gene expression signature of 2D and 3D cultured BRAFV600E mutant melanoma cell lines. We successfully developed BRAF-drug resistant cell lines from paired primary/metastatic melanoma cell lines in both 2D and 3D in vitro cultures. Using Affymetrix Human Gene 1.0 ST arrays, we determined the gene expression pattern of all cell lines. Our analysis revealed 1049 genes (562 upregulated and 487 downregulated) that were differentially expressed between drug-sensitive cells grown under different cell cultures. Pathway analysis showed that the differently expressed genes were mainly associated with the cell cycle, p53, and other cancer-related pathways. The number of upregulated genes (72 genes) was remarkably fewer when comparing the resistant adherent cells to cells that grow in 3D, and were associated with cell adhesion molecules and IGF1R signalling. Only 1% of the upregulated and 5.6% of the downregulated genes were commonly altered between the sensitive and the resistant spheroids. Interestingly, we found several genes (BNIP3, RING1 and ABHD4) with inverse expression signature between sensitive and resistant spheroids, which are involved in anoikis resistance and cell cycle regulation. In summary, our study highlights gene expression alterations that might help to understand the development of acquired resistance in melanoma cells in tumour tissue. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12253-020-00837-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7471197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-74711972020-09-16 Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids Koroknai, Viktoria Patel, Vikas Szász, István Ádány, Róza Balazs, Margit Pathol Oncol Res Original Article In vitro cell cultures are frequently used to define the molecular background of drug resistance. The majority of currently available data have been obtained from 2D in vitro cultures, however, 3D cell culture systems (spheroids) are more likely to behave similarly to in vivo conditions. Our major aim was to compare the gene expression signature of 2D and 3D cultured BRAFV600E mutant melanoma cell lines. We successfully developed BRAF-drug resistant cell lines from paired primary/metastatic melanoma cell lines in both 2D and 3D in vitro cultures. Using Affymetrix Human Gene 1.0 ST arrays, we determined the gene expression pattern of all cell lines. Our analysis revealed 1049 genes (562 upregulated and 487 downregulated) that were differentially expressed between drug-sensitive cells grown under different cell cultures. Pathway analysis showed that the differently expressed genes were mainly associated with the cell cycle, p53, and other cancer-related pathways. The number of upregulated genes (72 genes) was remarkably fewer when comparing the resistant adherent cells to cells that grow in 3D, and were associated with cell adhesion molecules and IGF1R signalling. Only 1% of the upregulated and 5.6% of the downregulated genes were commonly altered between the sensitive and the resistant spheroids. Interestingly, we found several genes (BNIP3, RING1 and ABHD4) with inverse expression signature between sensitive and resistant spheroids, which are involved in anoikis resistance and cell cycle regulation. In summary, our study highlights gene expression alterations that might help to understand the development of acquired resistance in melanoma cells in tumour tissue. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12253-020-00837-9) contains supplementary material, which is available to authorized users. Springer Netherlands 2020-07-01 2020 /pmc/articles/PMC7471197/ /pubmed/32613561 http://dx.doi.org/10.1007/s12253-020-00837-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Koroknai, Viktoria Patel, Vikas Szász, István Ádány, Róza Balazs, Margit Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids |
title | Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids |
title_full | Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids |
title_fullStr | Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids |
title_full_unstemmed | Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids |
title_short | Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids |
title_sort | gene expression signature of braf inhibitor resistant melanoma spheroids |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471197/ https://www.ncbi.nlm.nih.gov/pubmed/32613561 http://dx.doi.org/10.1007/s12253-020-00837-9 |
work_keys_str_mv | AT koroknaiviktoria geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids AT patelvikas geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids AT szaszistvan geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids AT adanyroza geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids AT balazsmargit geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids |